2452 J . Org. Chem., Vol. 61, No. 7, 1996
Linderman and Chen
4-[[1-(Dim eth ylflu or osilyl)h exyl]oxy]-1-n on en e, 34c: GC
tR 19.72 and 19.80 min (113:1); H NMR (CDCl3) δ 0.23 (t, 6
3411, 3074, 1251, 1072, 865, 735. Anal. Calcd for C18H29NO4-
Si: C, 61.50; H, 8.32. Found: C, 61.26; H, 8.37.
1
H, J ) 8 Hz), 0.87 (m, 6 H), 1.20-1.60 (m, 16 H), 2.18 (m, 2
H), 3.16 (t, 1 H, J ) 6.6 Hz), 3.31 (m, 1 H), 5.05 (m, 2 H), 5.78
(m, 1 H); 13C NMR (CDCl3) ppm -3.07 (-3.26), -2.36 (-2.55),
14.06, 22.55, 22.65, 25.04, 26.11, 30.70, 32.02, 32.28, 33.93,
38.39, 69.37 (69.60), 78.49, 116.62, 135.32; 19F NMR (CFCl3)
-163.8; IR (neat) (cm-1): 3080, 1640, 1250, 1040, 870.
4-[[1-(Hyd r oxyd im eth ylsilyl)h exyl]oxy]-1-n on en e, 35c
(82%): 1H NMR (CDCl3) δ 0.16 (s, 6 H), 0.89 (t, 6 H, J ) 6
Hz), 1.20-1.60 (m, 16 H), 2.22 (m, 2 H), 3.07 (t, 1 H, J ) 6
Hz), 3.36 (m, 1 H), 5.08 (m, 2 H), 5.83 (m, 1 H); 13C NMR
(CDCl3) ppm -1.91, -1.20, 14.02, 22.55, 22.62, 25.14, 26.37,
30.99, 31.99, 32.31, 34.22, 38.36, 70.93, 78.36, 116.94, 135.74;
IR (neat) (cm-1) 3400, 3080, 1640, 1250, 1035, 860. Anal. Calcd
for C17H36O2Si: C, 67.94; H, 12.07. Found: C, 68.03; H, 12.04.
4-Cycloh exyl-4-[[1-(h yd r oxyd im eth ylsilyl)h exyl]oxy]-
1-bu ten e, 35d (85%): 1H NMR (CDCl3) δ 0.13 (s, 6 H), 0.87
(t, 3 H, J ) 7 Hz), 1.00-1.72 (m, 19 H), 2.05 (s, 1 H), 2.20 (m,
2 H), 3.04 (t, 1 H, J ) 6 Hz), 3.14 (q, 1 H, J ) 5 Hz), 5.06 (m,
2 H), 5.82 (m, 1 H); 13C NMR (CDCl3) ppm -1.91, -1.16, 14.02,
22.52, 26.30, 26.40, 26.66, 28.60, 28.89, 30.66, 32.31, 34.67,
40.46, 70.38, 81.85, 116.78, 136.20; IR (neat) (cm-1) 3350, 3070,
1240, 1030, 860. Anal. Calcd for C18H36O2Si: C, 69.17; H,
11.61. Found: C, 69.01; H, 11.53.
4-P h e n yl-4-[[1-(h yd r oxyd im e t h ylsilyl)h e xyl]oxy]-1-
bu ten e, 35e (93%): 1H NMR (CDCl3) δ 0.20 (s, 3 H), 0.22 (s,
3 H), 0.78 (t, 3 H, J ) 6 Hz), 0.87-1.50 (m, 8 H), 2.02 (s, 1 H),
2.42 (m, 1 H), 2.58 (m, 1 H), 3.08 (t, 1 H, J ) 6 Hz), 4.32 (t, 1
H, J ) 6 Hz), 5.07 (m, 2 H), 5.81 (m, 1 H), 7.32 (m, 5 H); 13C
NMR (CDCl3) ppm -0.93, -0.28, 14.65, 23.11, 26.89, 32.06,
32.48, 43.18, 73.10, 83.56, 117.91, 127.83, 128.18, 128.76,
136.32, 143.63; IR (neat) (cm-1) 3450, 3070, 3030, 1250, 1060,
830, 700. Anal. Calcd for C18H30O2Si: C, 70.53; H, 9.87.
Found: C, 70.60; H, 9.89.
4-(4′-Bip h en ylyl)-4-[[1-(h yd r oxyd im et h ylsilyl)h exyl]-
oxy]-1-bu ten e, 35f (77%): 1H NMR (CDCl3) δ 0.19 (s, 3 H),
0.21 (s, 3 H), 0.74 (t, 3 H, J ) 7 Hz), 0.80-1.50 (m, 8 H), 2.12
(s, 1 H), 2.43 (m, 1 H), 2.60 (m, 1 H), 3.10 (t, 1 H, J ) 6 Hz),
4.35 (dd, 1 H, J ) 5 Hz, J ′ ) 8 Hz), 5.07 (m, 2 H), 5.86 (m, 1
H), 7.32-7.60 (m, 9 H); 13C NMR (CDCl3) ppm -1.68, -1.00,
13.96, 22.39, 26.17, 31.34, 31.76, 42.43, 72.41, 82.56, 117.33,
126.79, 127.02, 127.15, 127.54, 128.70, 135.58, 140.36, 140.91,
141.98; IR (neat) (cm-1) 3503, 3065, 3029, 1787, 1696, 734.
Anal. Calcd for C24H34O2Si: C, 75.34; H, 8.96. Found: C,
75.12; H, 8.93.
4-(2'-Naph th yl)-4-[[1-(h ydr oxydim eth ylsilyl)h exyl]oxy]-
1-bu ten e, 35g (75%): 1H NMR (CDCl3) δ 0.20 (s, 3 H), 0.22
(s, 3 H), 0.64 (t, 3 H, J ) 7 Hz), 0.80-1.45 (m 8 H), 2.05 (s, 1
H), 2.48 (m, 1 H), 2.65 (m, 1 H), 3.11 (dd, 1 H, J ) 6 Hz, J ′ )
7 Hz), 4.47 (dd, 1 H, J ) 5 Hz, J ′ ) 8 Hz), 5.06 (m, 2 H), 5.83
(m, 1 H), 7.47 (m, 3 H), 7.71 (s, 1 H), 7.81 (m, 3 H); 13C NMR
(CDCl3) ppm -1.68, -0.97, 13.80, 22.36, 26.21, 31.38, 31.70,
42.39, 72.14, 83.01, 117.33, 124.95, 125.66, 125.95, 126.18,
127.63, 127.80, 127.92, 133.00, 133.06, 135.55, 140.27; IR
(neat) (cm-1) 3406, 3058, 1250, 1069, 858, 778, 746. Anal.
Calcd for C22H32O2Si: C, 74.10; H, 9.05. Found: C, 74.38; H,
9.28.
4-[[1-(H yd r oxyd im et h ylsilyl)h exyl]oxy]-4-[4′-(r′,r′,r′-
tr iflu or om eth yl)p h en yl]-1-bu ten e, 35j (80%): 1H NMR
(CDCl3) δ 0.17 (s, 3 H), 0.20 (s, 3 H), 0.74 (t, 3 H, J ) 7 Hz),
0.90-1.45 (m, 8 H), 2.04 (s, 1 H), 2.38 (m, 1 H), 2.53 (m, 1 H),
3.05 (t, 1 H, J ) 7 Hz), 4.37 (dd, 1 H, J ) 6 Hz, J ) 7 Hz), 5.06
(m, 2 H), 5.74 (m, 1 H), 7.49 (dd, 4 H, J ) 9 Hz, J ′ ) 14 Hz);
13C NMR (CDCl3) ppm -1.71, -1.10, 13.83, 22.36, 26.21, 31.25,
31.76, 42.36, 73.09, 82.14, 117.78, 125.05, 127.28, 129.86,
134.81, 147.25; 19F NMR (CFCl3) -62.93; IR (neat) (cm-1) 3375,
1068, 865, 839. Anal. Calcd for C19H29F3O2Si: C, 60.93; H,
7.80. Found: C, 61.09; H, 7.85.
4-[[1-(H yd r oxyd im et h ylsilyl)h exyl]oxy]-4-[3′-(r′,r′,r′-
tr iflu or om eth yl)p h en yl]-1-bu ten e, 35k (73%): 1H NMR
(CDCl3) δ 0.17, (s, 3 H), 0.20 (s, 3 H), 0.74 (t, 3 H, J ) 7 Hz),
0.90-1.40 (m, 8 H), 2.05 (s, 1 H), 2.38 (m, 1 H), 2.53 (m, 1 H),
3.03 (t, 1 H, J ) 6 Hz,), 4.37 (dd, 1 H, J ) 5 Hz, J ′ ) 8 Hz),
5.06 (m, 2 H), 5.77 (m, 1 H), 7.39-7.58 (m, 5 H); 13C NMR
(CDCl3) ppm -1.75, -1.10, 13.86, 22.33, 26.33, 31.28, 31.80,
42.49, 73.12, 82.27, 117.81, 123.72, 123.79, 124.31, 125.95,
128.51, 130.41, 134.90, 144.77; 19F NMR (CFCl3) -64.07; IR
(neat) (cm-1) 3388, 3077, 1253, 1129, 567. Anal. Calcd for
C19H29F3O2Si: C, 60.93; H, 7.80. Found: C, 61.07; H, 7.92.
4-[[1-(H yd r oxyd im et h ylsilyl)h exyl]oxy]-4-[2′-(r′,r′,r′-
tr iflu or om eth yl)p h en yl]-1-bu ten e, 35l (72%): 1H NMR
(CDCl3) δ 0.17 (s, 3 H), 0.18 (s, 3 H), 0.72 (t, 3 H, J ) 7 Hz),
0.80-1.40 (m, 8 H), 2.03 (s, 1 H), 2.38 (m, 2 H), 3.05 (t, 1 H,
J ) 7 Hz), 4.75 (m, 1 H), 5.08 (m, 2 H), 5.92 (m, 1 H), 7.33 (t,
1 H, J ) 8 Hz), 7.55 (m, 2 H), 7.75 (d, 1 H, J ) 8 Hz); 13C
NMR (CDCl3) ppm -1.71, -1.04, 13.89, 22.30, 26.11, 31.25,
31.73, 43.59, 74.16, 78.23, 117.58, 124.92, 125.02, 127.18,
128.73, 131.71, 135.68, 143.34; 19F NMR (CFCl3) -59.20; IR
(neat) (cm-1) 3417, 3075, 1313, 1123, 834, 769.
4-[[1-(Hydr oxydim eth ylsilyl)h exyl]oxy]-4-(4′-m eth ylph e-
n yl)-1-bu ten e, 35m (78%): 1H NMR (CDCl3) δ 0.17 (s, 3 H),
0.19 (s, 3 H), 0.76 (t, 3 H, J ) 8 Hz), 0.90-1.45 (m, 8 H), 2.29
(s, 1 H), 2.33 (s, 3 H), 2.36 (m, 1 H), 2.56 (m, 1 H), 3.04 (t, 1 H,
J ) 6 Hz), 4.26 (dd, 1 H, J ) 6 Hz, J ′ ) 7 Hz), 5.05 (m, 2 H),
5.81 (m, 1 H), 7.15 (dd, 4 H, J ) 8 Hz, J ′ ) 24 Hz); 13C NMR
(CDCl3) ppm -1.65, -0.97, 13.96, 21.10, 22.46, 26.17, 31.38,
31.76, 42.43, 71.99, 82.59, 117.13, 127.08, 128.76, 135.81,
137.10, 139.82; IR (neat) (cm-1) 3405, 3076, 1251, 1069, 846,
833, 780, 735. Anal. Calcd for C19H32O2Si: C, 71.19; H, 10.06.
Found: C, 70.95; H, 9.97.
4-[[1-(H yd r oxyd im et h ylsilyl)h exyl]oxy]-4-(2′,4′,6′-t r i-
m eth ylp h en yl)-1-bu ten e, 35n (34%): 1H NMR (CDCl3) δ
0.16 (s, 3 H), 0.17 (s, 3 H), 0.73 (t, 3 H, J ) 7 Hz), 0.87-1.60
(m, 8 H), 2.04 (s, 1 H), 2.20 (s, 3 H), 2.25-2.50 (m, 7 H), 2.71
(m, 1 H), 3.05 (t, 1 H, J ) 6 Hz), 4.68 (dd, 1 H, J ) 6 Hz, J ′ )
8 Hz), 5.07 (m, 2 H), 5.80 (m, 1 H), 6.78 (m, 2 H); 13C NMR
(CDCl3) ppm (major diastereomer) -1.65, -1.10, 13.89, 20.71,
20.84, 22.36, 26.04, 31.12, 31.96, 39.94, 75.00, 80.52, 116.91,
128.89, 130.12, 131.22, 135.71, 136.10, 136.16, 136.46; IR
(neat) (cm-1) 3405, 3076, 1612, 1250, 1057, 851, 782. Anal.
Calcd for C21H36O2Si: C, 72.36; H, 10.41. Found: C, 72.62;
H, 10.31.
4-[4-(Meth yloxy)p h en yl]-1,6-h ep ta d ien e, 38 (31%): 1H
NMR (CDCl3) δ 2.33 (m, 4 H), 2.65 (m, 1 H), 3.77 (s, 3 H), 4.92
(m, 2 H), 5.63 (m, 1 H), 6.81 (d, 2 H, J ) 9 Hz), 7.05 (d, 2 H,
4-(2′-Br om oph en yl)-4-[[1-(h ydr oxydim eth ylsilyl)h exyl]-
oxy]-1-bu ten e, 35h (72%): 1H NMR (CDCl3) δ 0.19 (s, 3 H),
0.20 (s, 3 H), 0.76 (t, 3 H, J ) 8 Hz), 0.80-1.55 (m, 8 H), 2.15
(s, 1 H), 2.41 (t, 2 H, J ) 8 Hz), 3.09 (t, 1 H, J ) 7 Hz), 4.83
(m, 1 H), 5.07 (m, 2 H), 5.87 (m, 1 H), 7.11 (m, 1 H), 7.28 (m,
1 H), 7.49 (m, 2 H); 13C NMR (CDCl3) ppm -1.65, -1.03, 13.89,
22.33, 26.27, 31.31, 31.80, 41.72, 73.87, 80.88, 117.49, 122.50,
127.28, 128.64, 132.16, 135.19, 142.56; IR (neat) (cm-1) 3412,
3074, 1072, 910, 865, 735. Anal. Calcd for C18H29BrO2Si: C,
56.09; H, 7.58. Found: C, 55.84; H, 7.59.
J
) 9 Hz); 13C NMR (CDCl3) ppm 40.46, 44.69, 55.13,
113.55,113.71, 115.97, 128.54, 136.65, 136.91; IR (neat) (cm-1
)
3067, 3032, 1602, 1240, 1030, 821; HRMS calcd for C14H18
202.1358, found 202.1347.
O
(b) r,â-Un sa tu r a ted Ald eh yd es. A slightly modified
reaction procedure compared to that described above was
employed for reactions of 1a with trans-cinnamaldehyde or
trans-crotonaldehyde. The reaction mixture was stirred at
-78 °C for 1 h after the addition of the Lewis acid, gradually
warmed to -40 °C, stirred at -40 °C for 1 h, and then warmed
to -20 to -10 °C, and stirred for an additional 1.5 h. Reaction
progress was monitored by TLC until the starting aldehyde
was consumed.
4-(4′-Nitr op h en yl)-4-[[1-(h yd r oxyd im eth ylsilyl)h exyl]-
oxy]-1-bu ten e, 35i (85%): 1H NMR (CDCl3) δ 0.17 (s, 3 H),
0.20 (s, 3 H), 0.75 (t, 3 H, J ) 7 Hz), 0.99-1.45 (m, 8 H), 1.92
(s, 1 H), 2.39 (m, 1 H), 2.51 (m, 1 H), 3.06 (t, 1 H, J ) 7 Hz),
4.56 (m, 1 H), 5.01 (m, 2 H), 5.73 (m, 1 H), 7.47 (d, 2 H, J ) 8
Hz), 8.17 (d, 2 H, J ) 9 Hz); 13C NMR (CDCl3) ppm -1.75,
-1.31, 13.89, 22.36, 26.27, 31.25, 31.83, 42.30, 73.61, 81.69,
3-[[1-(Hyd r oxyd im eth ylsilyl)h exyl]oxy]-1-p h en yl-1,5-
h exa d ien e, 39 (55%): 1H NMR (CDCl3) δ 0.19 (s, 3 H), 0.20
(s, 3 H), 0.79 (t, 3 H, J ) 7 Hz), 1.15-1.65 (m, 8 H), 2.04 (s, 1
118.17, 123.40, 127.63, 134.23, 147.28, 150.93; IR (neat) (cm-1
)